Electromedical Products International, Inc.
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 1981-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.alpha-stim.com
Clinical Trials
6
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
CES for the Treatment of GAD in Young Adults
- Conditions
- Generalized Anxiety Disorder
- First Posted Date
- 2023-11-09
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- Electromedical Products International, Inc.
- Target Recruit Count
- 130
- Registration Number
- NCT06124014
- Locations
- 🇺🇸
Carolina Center for Neurostimulation, Chapel Hill, North Carolina, United States
Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of Depression
- Conditions
- DepressionMajor Depressive DisordertACS
- First Posted Date
- 2023-03-16
- Last Posted Date
- 2025-05-29
- Lead Sponsor
- Electromedical Products International, Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT05772702
- Locations
- 🇺🇸
Carolina Center for Neurostimulation, Chapel Hill, North Carolina, United States
Alpha-Stim AID and Major Depressive Disorder
- Conditions
- Depressive Disorder, Major
- First Posted Date
- 2021-07-15
- Last Posted Date
- 2021-07-15
- Lead Sponsor
- Electromedical Products International, Inc.
- Target Recruit Count
- 230
- Registration Number
- NCT04963907
- Locations
- 🇬🇧
University of Nottingham, Nottingham, United Kingdom
Neural Mechanisms With CES in Depression
- Conditions
- Depression
- First Posted Date
- 2020-10-14
- Last Posted Date
- 2023-11-24
- Lead Sponsor
- Electromedical Products International, Inc.
- Target Recruit Count
- 1
- Registration Number
- NCT04587531
- Locations
- 🇬🇧
Oxford Brooke University, Oxford, United Kingdom
Efficacy of Cranial Electrotherapy Stimulation (CES) for the Treatment of Major Depressive Disorder
- Conditions
- Major Depressive Disorder
- First Posted Date
- 2017-07-19
- Last Posted Date
- 2023-04-27
- Lead Sponsor
- Electromedical Products International, Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT03222752
- Locations
- 🇺🇸
Advanced Psychotherapeutics, Forest, Virginia, United States
- Prev
- 1
- 2
- Next
News
FDA Grants Breakthrough Device Designations for Novel Neuromodulation Therapies Targeting PTSD and MDD
• Wave Neuroscience's MeRT system received FDA Breakthrough Device Designation for adjunctive treatment of PTSD, addressing the critical need for effective, non-pharmacologic options. • Pulvinar Neuro, a subsidiary of EPI, obtained FDA Breakthrough Device Designation for its Closed-Loop tACS device, aiming to provide rapid relief from Major Depressive Disorder (MDD) symptoms. • Both devices leverage personalized neuromodulation techniques, tailoring treatment to individual brain activity patterns, potentially transforming mental health care. • The FDA's designation is expected to accelerate the development and review processes for these innovative therapies, offering hope for improved outcomes in underserved patient populations.